SCHEMBL7712416

SCHEMBL7712416

Cc1ccc(Oc2cnc(N)nc2N2CCOCC2)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 1/20 0.52
CYP1A2 P05177 2/20 0.46
CYP3A4 P08684 2/20 0.46
CYP2C19 P33261 2/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
PIK3CA P42336 7/20 0.46
MTOR P42345 7/20 0.46
AKT1 P31749 5/20 0.46
NOS1 P29475 1/20 0.46
TRPM8 Q7Z2W7 2/20 0.44
PIK3R1 P27986 2/20 0.43
ALDH1A1 P00352 2/20 0.43
DHFR P00374 1/20 0.43
CYP2C9 P11712 1/20 0.43
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
ADORA2A P29274 1/20 0.42
NUDT1 P36639 1/20 0.41
CCNC P24863 1/20 0.40
CDK8 P49336 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7714247 0.88 MEN1 (0.53) PIK3CAMTORAKT1NOS1TRPM8
SCHEMBL7714124 0.88 MTOR (0.44) MAPK1SMN1; SMN2PIK3CAMTORAKT1
SCHEMBL7714121 0.87 PIK3CA (0.55) PIK3CAMTORAKT1NOS1TRPM8
SCHEMBL7714309 0.83 DHFR (0.39) PIK3CAMTORALDH1A1DHFRMEN1
SCHEMBL8156197 0.82 MEN1 (0.48) MAPK1PIK3CAMTORAKT1NOS1
SCHEMBL7714556 0.80 KMT2A (0.44) SMN1; SMN2ALDH1A1DHFRMEN1KMT2A
SCHEMBL18072393 0.75 PIK3CA (0.54) PIK3CAMTORNOS1PIK3R1DHFR
SCHEMBL7708416 0.75 HRH4 (0.55) DHFR
SCHEMBL7714150 0.73 MEN1 (0.61) MAPK1CYP1A2CYP3A4CYP2C19TRPM8
SCHEMBL7712410 0.73 HRH4 (0.52) SMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6440965-B1 Substituted pyrimidine derivatives, their preparation and their use in the treatment of neurodegenerative or neurological disorders of the central nervous system KRENITSKY PHARMACEUTICALS, INC. 2002-08-27 US claimed
EP-1025091-A1 SUBSTITUTED PYRIMIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE OR NEUROLOGICAL DISORDERS OF THE CENTRAL NERVOUS SYSTEM Krenitsky Pharmaceuticals, Inc. (US) 2000-08-09 EP claimed
WO-1999019305-A2 SUBSTITUTED PYRIMIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE OR NEUROLOGICAL DISORDERS OF THE CENTRAL NERVOUS SYSTEM KRENITSKY PHARMACEUTICALS INC. (US) 1999-04-22 WO claimed
US-6440965-B1 Substituted pyrimidine derivatives, their preparation and their use in the treatment of neurodegenerative or neurological disorders of the central nervous system KRENITSKY PHARMACEUTICALS, INC. 2002-08-27 US disclosed
EP-1025091-A1 SUBSTITUTED PYRIMIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE OR NEUROLOGICAL DISORDERS OF THE CENTRAL NERVOUS SYSTEM Krenitsky Pharmaceuticals, Inc. (US) 2000-08-09 EP disclosed
WO-1999019305-A2 SUBSTITUTED PYRIMIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE OR NEUROLOGICAL DISORDERS OF THE CENTRAL NERVOUS SYSTEM KRENITSKY PHARMACEUTICALS INC. (US) 1999-04-22 WO disclosed